Status:

COMPLETED

Closed-loop System Using Transcranial Direct Current Stimulation (tDCS) for Epilepsy

Lead Sponsor:

Spaulding Rehabilitation Hospital

Conditions:

Epilepsy

Seizures

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

In this pilot study, the researchers investigated the feasibility of a closed-loop electroencephalography (EEG) / transcranial direct current stimulation (tDCS) system for treatment of epilepsy. They ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Epileptics)
  • Disabling motor simple partial seizures, complex partial seizures, and/or secondarily generalized seizures. Disabling refers to seizures that are severe enough to significantly impair functional abilities in areas such as employment, psychological or social wellbeing, education or mobility.
  • Failed treatment with a minimum of two antiepileptic medications.
  • Experienced an average of three or more disabling simple weekly partial seizures, complex partial seizures and/or secondarily generalized seizures.
  • Between the ages of 18 and 70 years.
  • No more than two epileptogenic regions in the brain.
  • Must be able to provide informed consent themselves.
  • Exclusion Criteria
  • Has a progressive neurological or systemic disease.
  • Has a history of nonepileptic seizures.
  • Has an implanted metallic device, aneurysm clips, cochlear implants, or spinal cord stimulator.
  • Has suffered a severe traumatic brain injury with skull fracture.
  • Contraindications to tDCS
  • metal in the head
  • implanted brain medical devices
  • Pregnancy
  • Any implanted electrical medical device, including pacers and implanted cardiac defibrillators
  • Inclusion criteria (Healthy Subjects)
  • \- Healthy subjects age 18 and older
  • Exclusion criteria:
  • Existence of major neurologic or psychiatric condition (i.e. epilepsy, severe depression)
  • History of head injury resulting in more than a momentary loss of consciousness
  • Previous neurosurgery
  • A history of significant alcohol or drug abuse in the prior 6 months
  • Presence of unstable medical conditions, such as; uncontrolled diabetes mellitus, cardiac pathology, cancer, kidney insufficiency, acute thrombosis
  • Contraindication to tDCS
  • metal in the head
  • implanted electronic medical devices
  • Pregnancy

Exclusion

    Key Trial Info

    Start Date :

    July 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2014

    Estimated Enrollment :

    6 Patients enrolled

    Trial Details

    Trial ID

    NCT01415362

    Start Date

    July 1 2011

    End Date

    July 1 2014

    Last Update

    April 24 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Spaulding Rehabilitation Hospital

    Boston, Massachusetts, United States, 02114